Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole vs Metronidazole + Lactobacillus for BV Recurrence
NCT03099408Phase 4Completed
- Sponsor
- Peking University Shenzhen Hospital
- Start
- Jul 2017
- Primary completion
- Dec 2020
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of live double combined lactobacillus in bacterial vaginosis (BV), sponsored by Peking University Shenzhen Hospital. Started Jul 2017; status: completed.
02
Drugs
live double combined lactobacillus
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT03099408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03099408.